Activation of the CXCL12/CXCR4 signaling axis may drive vascularization of the ovine placenta

被引:31
|
作者
Quinn, K. E. [1 ]
Ashley, A. K. [1 ]
Reynolds, L. P. [2 ]
Grazul-Bilska, A. T. [2 ]
Ashley, R. L. [1 ]
机构
[1] New Mexico State Univ, Dept Anim & Range Sci, Las Cruces, NM 88003 USA
[2] N Dakota State Univ, Ctr Nutr & Pregnancy, Dept Anim Sci, Fargo, ND 58108 USA
基金
美国食品与农业研究所;
关键词
CXCL12; CXCR4; VEGF; Vascularization; Pregnancy; Sheep; STROMAL-DERIVED FACTOR-1-ALPHA; ENDOTHELIAL GROWTH-FACTOR; MATERNAL-FETAL INTERFACE; CHEMOKINE RECEPTOR CXCR4; REGULATORY T-CELLS; EARLY-PREGNANCY; TH2; BIAS; FACTOR-I; ANGIOGENESIS; EXPRESSION;
D O I
10.1016/j.domaniend.2013.12.004
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Early pregnancy, when most embryonic losses occur, is a critical period in which vital placental vascularization is established. Vascular endothelial growth factor (VEGF) is a potent inducer of angiogenesis, and factors that regulate VEGF function, expression, or both may ultimately affect vascularization. Activation of the C-X-C chemokine receptor type 4 (CXCR4) by its cognate ligand, C-X-C chemokine ligand 12 (CXCL12), increases VEGF synthesis and secretion, which in turn stimulates CXCL12 and CXCR4 production and this synergistic regulation may influence placental vascularization. We hypothesized that expression of CXCL12, CXCR4, select angiogenic factors, and their receptors would increase in placental tissues during early pregnancy and that treatment of ovine trophectoderm cells with CXCL12 would increase production of angiogenic factors. To test this hypothesis, maternal caruncle (CAR) and fetal extraembryonic membrane (FM) tissues were collected on days 18, 20, 22, 25, 26, and 30 of pregnancy and on day 10 of the estrous cycle (control, NP) to determine relative mRNA or protein expression of CXCL12 and CXCR4 and selected angiogenic factors. In CAR, expression of mRNA for CXCR4 increased on day 18, 20, 22, and 25 and CXCL12 increased on day 18 and 20 compared with NP ewes. CXCL12 protein followed a similar pattern in CAR tissue, with greater levels on day 20 than in NP tissue. Greater levels of fibroblast growth factor 2 (FGF2) mRNA was observed in CAR on day 20 of gestation than on day 30. In FM, CXCL12, CXCR4, angiopoietin 1, VEGF, and VEGF receptor 1 were enhanced with advancing pregnancy, whereas FGF2 and kinase insert domain receptor (or VEGF receptor 2) peaked on day 25. An increase in protein levels occurred on day.25 compared with day 20 in FM for CXCL12 and CXCR4, as well as a similar tendency for FGF2 protein. Both CXCL12 and CXCR4 are specifically localized to trophoblast cells and to the uterine luminal and glandular epithelium. Treatment of ovine trophectoderm cells with CXCL12 increased mRNA expression for VEGF and FGF2. The relationship between VEGF, FGF2, and the CXCL12/CXCR4 signaling underscores the potential role for this chemokine axis in driving placentation. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:11 / 21
页数:11
相关论文
共 50 条
  • [31] CXCL12/CXCR4 axis in the microenvironment of solid tumors: A critical mediator of metastasis
    Mortezaee, Keywan
    LIFE SCIENCES, 2020, 249
  • [32] Chemokine CXCL12 Activates CXC Receptor 4 Metastasis Signaling Through the Upregulation of a CXCL12/CXCR4/MDMX (MDM4) Axis
    Lee, Rusia
    Ellison, Viola
    Forbes, Dominique
    Gao, Chong
    Katanov, Diana
    Kern, Alexandra
    Levine, Fayola
    Leybengrub, Pam
    Ogunwobi, Olorunseun
    Xiao, Gu
    Feng, Zhaohui
    Bargonetti, Jill
    CANCERS, 2024, 16 (24)
  • [33] Expression Analysis of Angiogenic Growth Factors and Biological Axis CXCL12/CXCR4 Axis in Idiopathic Pulmonary Fibrosis
    Antoniou, Katerina M.
    Soufla, Giannoula
    Lymbouridou, Rena
    Economidou, Foteini
    Lasithiotaki, Ismini
    Manousakis, Manolis
    Drositis, Ioannis
    Spandidos, Demetrios A.
    Siafakas, Nikolaos M.
    CONNECTIVE TISSUE RESEARCH, 2010, 51 (01) : 71 - 80
  • [34] The chemokine receptor CXCR4 and its ligand CXCL12 are activated during implantation and placentation in sheep
    Ashley, Ryan L.
    Antoniazzi, Alfredo Q.
    Anthony, Russell V.
    Hansen, Thomas R.
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2011, 9
  • [35] CXCL12/CXCR4 signaling pathway regulates cochlear development in neonatal mice
    Zhang, Wen
    Sun, Ji-Zhou
    Han, Yu
    Chen, Jun
    Liu, Hui
    Wang, Ye
    Yue, Bo
    Chen, Yang
    MOLECULAR MEDICINE REPORTS, 2016, 13 (05) : 4357 - 4364
  • [36] The Signaling Duo CXCL12 and CXCR4: Chemokine Fuel for Breast Cancer Tumorigenesis
    Zielinska, Karolina A.
    Katanaev, Vladimir L.
    CANCERS, 2020, 12 (10) : 1 - 21
  • [37] Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis
    Conley-LaComb, M. Katie
    Semaan, Louie
    Singareddy, Rajareddy
    Li, Yanfeng
    Heath, Elisabeth I.
    Kim, Seongho
    Cher, Michael L.
    Chinni, Sreenivasa R.
    MOLECULAR CANCER, 2016, 15
  • [38] The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease
    Doering, Yvonne
    Pawig, Lukas
    Weber, Christian
    Noels, Heidi
    FRONTIERS IN PHYSIOLOGY, 2014, 5
  • [39] Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer
    Mao, T. L.
    Fan, K. F.
    Liu, C. L.
    GENE THERAPY, 2017, 24 (10) : 621 - 629
  • [40] Potential of CXCR4/CXCL12 Chemokine Axis in Cancer Drug Delivery
    Wang Y.
    Xie Y.
    Oupický D.
    Current Pharmacology Reports, 2016, 2 (1) : 1 - 10